QuercetinNew
Quercetin is a plant flavonoid found in onions, apples, and berries, valued for its antioxidant, anti-inflammatory, and mast-cell-stabilizing effects, and increasingly studied as part of the senolytic drug combination dasatinib plus quercetin (D+Q). Small 2025 pilot trials — including one in older adults at risk for Alzheimer's disease and another in adults with schizophrenia, schizoaffective disorder, or treatment-resistant depression — report that intermittent D+Q dosing is feasible and safe and may lower inflammatory markers like TNF-alpha, though these studies used quercetin combined with the prescription drug dasatinib rather than quercetin alone. Taken by itself, quercetin has more established human evidence for reducing seasonal allergy symptoms through mast-cell stabilization and for modestly speeding recovery after exercise-induced muscle damage, per a 2023 systematic review and meta-analysis of randomized trials. Because quercetin's plain aglycone form is poorly absorbed, many supplements use phytosome, liposomal, or enzymatically modified forms to improve bioavailability. Individual results vary; senolytic (D+Q) protocols specifically should only be pursued under physician supervision, since they involve prescription-strength dasatinib, not quercetin alone.
Mechanism of Action
Quercetin scavenges reactive oxygen species and upregulates endogenous antioxidant enzyme pathways (e.g., Nrf2), while dampening NF-kB signaling to reduce inflammatory cytokine production. It stabilizes mast cells and basophils, limiting histamine release, which underlies its anti-allergy effects. In preclinical senolytic research, quercetin is thought to inhibit anti-apoptotic PI3K/AKT and BCL-2-family pathways in senescent cells, complementing dasatinib's tyrosine-kinase inhibition to help selectively clear these cells — an effect demonstrated mainly in animal models and small human pilot trials of the combination, not quercetin given alone.
Dosing Protocol
500-1000mg per day, typically split into two dosesmg
Standard starting dose based on research
Therapeutic Range
500
Minimum
1000
Maximum
With meals to improve absorption and reduce GI upset; commonly split morning and evening
Cycling Protocol
Standard antioxidant/allergy use is typically continuous. Senolytic (D+Q) research protocols instead use intermittent, physician-supervised dosing (e.g., short pulses on consecutive days, repeated periodically) alongside prescription dasatinib — this is not a self-directed cycling regimen.
Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.
Benefits
Primary Benefits
- Antioxidant protection
- Allergy and mast-cell stabilization
- Anti-inflammatory support
- Exercise recovery
Secondary Benefits
Safety Information
Contraindications
Do not use if any of the following apply:
- •Pregnancy and breastfeeding (insufficient safety data)
- •Pre-existing kidney disease or renal impairment
- •Use of anticoagulant or antiplatelet medications without medical supervision
- •Surgery within 2 weeks (antiplatelet effects)
- •Combining with dasatinib or other senolytic protocols outside physician supervision
Drug/Supplement Interactions
May interact with the following. Consult a healthcare provider before combining:
Potential Side Effects
Some users may experience:
This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.
Quality Markers
Look for these specific quality indicators when sourcing this compound:
- Quercetin phytosome or liposomal form for enhanced bioavailability
- Standardized quercetin dihydrate/anhydrous content
- Third-party tested for purity and heavy metals
Trusted Certifications
Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.
Evidence Profile
Evidence Score
6/10
Moderate Evidence
Some clinical trials with positive results, emerging research
Evidence Scale
8-10
Strong
5-7
Moderate
1-4
Emerging
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation